On June 23, 2026, in Berkeley, California, Profusa, Inc. (Nasdaq: PFSA), a leading digital health company specializing in advanced biosensing technologies, disclosed that all resolutions put forth at the 2026 Annual Meeting of Shareholders received approval from the shareholders. The event signaled a successful outcome for the company's proposals.